A Phase 3, Double-Blind, Randomized, Placebo-Controlled Study of Levosimendan in Pulmonary Hypertension Patients With Heart Failure With Preserved Left Ventricular Ejection Fraction(PH-HFpEF); LEVEL:LEVosimendan to Improve Exercise Limitation in Pa